TRCT
BFRI icon

Tower Research Capital (TRC)’s Biofrontera BFRI Stock Holding History

Tower Research Capital (TRC)’s Portfolio BFRI Stock Details BFRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$314 Buy
+332
New +$328 ﹤0.01% 5069
2025
Q1 		– Sell
-4,539
Closed -$4.95K – 5205
2024
Q4 		$4.95K Buy
4,539
+4,263
+1,545% +$4.03K ﹤0.01% 4372
2024
Q3 		$367 Sell
276
-10,215
-97% -$11.7K ﹤0.01% 5359
2024
Q2 		$9.42K Buy
10,491
+8,586
+451% +$11.9K ﹤0.01% 4256
2024
Q1 		$2.93K Sell
1,905
-1,268
-40% -$1.76K ﹤0.01% 4962
2023
Q4 		$8.79K Buy
+3,173
New +$13.8K ﹤0.01% 4464
2023
Q3 		– Sell
-655
Closed -$6.82K – 5950
2023
Q2 		$6.82K Sell
655
-7
-1% -$74 ﹤0.01% 4656
2023
Q1 		$8K Buy
662
+450
+212% +$7.02K ﹤0.01% 4608
2022
Q4 		$4K Sell
212
-221
-51% -$4.51K ﹤0.01% 4978
2022
Q3 		$9K Buy
+433
New +$11.8K ﹤0.01% 4634
2022
Q1 		– Sell
-8
Closed -$1K – 6089
2021
Q4 		$1K Buy
+8
New +$876 ﹤0.01% 5786

Other funds holding BFRI

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Tower Research Capital (TRC)'s BFRI Position: Q2 2026 in Review

Tower Research Capital (TRC) opened a new position in Biofrontera (BFRI) in Q2 2026: 332 shares worth $314. The stake represents ﹤0.01% of the portfolio and ranks #5069 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in BFRI as recently as Q4 2024.

Tower Research Capital (TRC) first reported a position in BFRI in Q4 2021 and has held it in 11 quarters since. The position peaked at $9.42K in Q2 2024. 19 funds tracked by Wall St. Rank hold BFRI as of Q2 2026.

  • Tower Research Capital (TRC) held 332 shares of Biofrontera worth $314 as of Q2 2026.
  • Biofrontera was a new Tower Research Capital (TRC) position in Q2 2026.
  • Biofrontera made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #5069 holding.
  • Tower Research Capital (TRC) first reported a position in Biofrontera in Q4 2021 and has held it in 11 quarters since.
  • Tower Research Capital (TRC)'s Biofrontera position peaked at $9.42K in Q2 2024.
  • 19 funds tracked by Wall St. Rank held Biofrontera as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.